Influenza and pneumococcal vaccine coverage among a random sample of hospitalised Victorians aged 65 years and over.

Andrews R, Skull S, Byrnes G, Campbell D, Turner J, McIntyre P, Kelly H.
Commun Dis Intell 2005: 29;283-288.

Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.

Bell SJ, Lau A, Thompson A, Watson KJ, Demediuk B, Shaw G, Chen RY, Ayres A, Yuen L, Bartholomeusz A, Locarnini SA, Desmond PV.
J Clin Virol 2005; 32(2):122-127.

Human coronavirus OC43 causes influenza-like illness in residents and staff of aged care facilities in Melbourne, Australia.

Birch C, Clothier H, Seccull A, Tran T, Catton M, Lambert S, Druce J.
Epidemiol Infect 2005; 133: 273-277.

Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.

Bowden S, McCaw R, White P, Crofts N, Aitken C.
J Viral Hepat 2005; 12: 322-324.

Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature.

Braue A, Ross G, Varigos G, Kelly H.
J Pediatr Dermatol 2005; 22:287-294.

Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis.

Britton WJ, Gilbert GL, Wheatley J, Leslie D, Rothel JS, Jones SL, Bradley P
Tuberculosis (Edinb). 2005; 85(3):137-45

Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong region.

Caruana SR, Kelly H, De Silva S, Chea L, Nuon S, Sakayo P, Bak N, Biggs BA.
Aust NZ J Public Health 2005; 29:64-68.

Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C.

Chan HL, Tsui S, Tse C, Ng E, Au T, Yuen L, Bartholomeusz A, Leung K, Lee K, Locarnini S, Sung J.
J Infect Dis 2005; 15;191(12):2022-2032.

Reduced Hepatitis B virus (HBV) specific CD4+ T-cell responses in Human immunodeficiency virus and HBV co-infected individual receiving HBV active retroviral Therapy.

Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent S, Sasadeusz J, Lewin S.
J Virol 2005; 79: 3038-3051.

Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates a genetic shift between chronologically distinct strains.

Chibo D, Birch C.
J Gen Virol : submitted

Applicability of oral fluid collected onto filter paper for detection and genetic characterisation of measles virus strains.

Chibo D, Riddell M, Catton M, Birch C.
J Clin Microbiol 2005; 43:3145-3149.

Evaluation of the Australian sentinel practice research network.

Clothier H, Fielding J, Kelly H.
Commun Dis Intell 2005: 29; 231-247

Hepatitis E infections, Victoria, Australia.

Cowie B, Adamopolous J, Carter K, Kelly H.
Emerg Infect Dis 2005; 11: 482-484

Hepatitis E virus: overseas epidemics and Victorian travellers.

Cowie B, Breschkin A, Kelly H.
Med J Aust 2005: 183:491

Salmonellosis, food-borne – Australia (Victoria).

Cowie BC, Sasadeusz J.
ProMED. Jan 23, 2005. [cited April 7 2005]. Archive number: 20050123.0239. Available from Promed.

Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens.

Dimitriadis A and Marshall JA (2005).
European Journal of Clinical Microbiology and Infectious Diseases. 24: 615-618

Laboratory diagnosis and surveillance by PCR of human respiratory viruses in Melbourne, Australia 2002-3.

Druce J, Tran T, Kelly H, Kaye M, Chibo D, Kostecki R, Amiri A, Catton M, Birch C.
J Med Virol 2005; 75:122-129.

What factors facilitated a high GP survey response rate?

Fielding J, Clothier H, Stocks N, Kelly H.
Aust Fam Phys 2005: 34: 895-896

The Global Phylogeny of Mycobacterium tuberculosis based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis evolution, Phylogenetic Accuracy and other DNA Fingerprinting Systems and Recommendations for a Minimal Standard SNP SET

Filliol, I., A. S. Motiwala, M. Cavatore, W. Qi, M. H. Hazbón, M. Bobadilla del Valle, J. Fyfe, L. García-García, N. Rastogi, C. Sola, T. Zozio, M. I. Guerrero, C. I. León, J. Crabtree, S. Angiuoli, K. D. Eisenach, R. Durmaz, M. L. Joloba, A. Rendón, J. Sifuentes-Osornio,
A. Ponce de León, M. D. Cave, R. Fleischmann, T. S. Whittam, and D. Alland.
J. Bacteriol. 2005: in press

Estimating influenza vaccine effectiveness in an outbreak when anti-viral medications are used as a control measure.

Guy R, Lambert S, Kelly H.
Aust NZ J Public Health 2005: in press

A sustained increase in infectious syphilis notifications in Victoria.

Guy R, Leslie D, Simpson K, Hatch B, Leydon J, Hellard M, Kelly H.
Med J Aust 2005: 183; 218

The role of embB306 mutations in Mycobacterium tuberculosis revisited: A novel association with broad drug resistance and clustering rather than ethambutol resistance.

Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Varma-Basil, M., Filliol, I., Cavatore, M., Colangeli, R., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., Davidow, A., Brimacombe, M., León, C. I., Porras, T., Bose, M., Chaves, F., Eisenach, K. D.,
Sifuentes-Osornio, J., Ponce-de-León, A., Cave, M. D., and Alland, D.
Antimicrob. Agents Chemother. 2005; 49: 3794-3802

Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation.

Hui CK, Yu J, Au WY, Zhang HY, Bartholomeusz A, Locarnini S, Kwong YL, Liang R, Lau GK.
J Clin Virol 2005; 32:173-178.

Detection of rubella IgM from dried venous blood using a commercial enzyme immunoassay.

Karapanagiotidis T, Riddell M, Kelly H.
Diag Microbiol Infect Dis 2005: 53:107-111

Replication of SARS-CoV in cells used in diagnostic virology laboratories.

Kaye M, Druce J, Tran T, Kostecki R, Morris J, Catton M, Birch C.
Emerging Inf Dis 2005: in press

Evidence that the association between oral poliovirus vaccine and transverse myelitis may be causal: a case history and review of the literature.

Kelly H.
J Paediatr Child Health 2005: in press

Human parvovirus causes rash among patients suspected to have measles or rubella.

Kelly H, Leydon J.
Eurosurveillance 2005: 10(9) www.eurosurveillance.org

Influenza vaccination and mortality in the US.

Kelly H, Vu T, Smith D.
Arch Intern Med 2005: 165:2037-2038

Molecular Characterisation of Isoniazid-Resistant Mycobacterium tuberculosis Isolates Collected in Australia.

Lavender, C., M. Globan, A. Sievers, H. Billman-Jacobe, and Fyfe, J.
Antimicrob. Agents Chemother. 2005; 49: 4068-4074

Report of the hands-on training/workshop on the laboratory diagnosis of measles virus infection.

Leydon J, Curley S, Karapanagiotidis T, Stambos V, Kelly H.
Pacific Dialogue 2005: in press

Therapies for hepatitis B: where to from here?

Locarnini, S. (2005).
Gastroenterology 128(3): 789-92

Hepatitis C and hepatitis E vaccines: research update.

Locarnini, S. (2005).
Med J Malaysia 60 Suppl B: 116-24

Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells.

Locarnini S, Shaw T, Dean J, Colledge D, Thompson A, Li K, Lemon S, Lau G, Beard MR.
J Clin Virol 2005; 32(2):113-121.

Molecular virology and the development of resistant mutants: implications for therapy.

Locarnini S.
Semin Liver Dis 2005; 25 Suppl 1:9-19.

Interpretation and application of virological testing including resistance in chronic hepatitis B.

Locarnini S
Med J Malaysia 2005; 60 Suppl B:41-51.

Hepatitis B vaccine and multiple sclerosis.

MacIntyre CR, Kelly H, Jolley D, Butzkueven H, Salmon D, Halsey N, Moulton LH.
Neurology 2005; 64:1317.

The role of electron microscopy in the detection and characterisation of viruses associated with gastroenteritis in humans.

Marshall JA (2005).
Chapter 14, pp167-190 in :A compendium of laboratory diagnostic methods for the common and unusual enteric pathogens- an Australianperspective.
Ed by CJ McIver.Australian Society for Microbiology Inc, Melbourne

Molecular and epidemiological features of norovirus-associated gastroenteritis outbreaks in Victoria, Australia in 2001.

Marshall JA, Dimitriadis A and Wright PJ (2005).
The Journal of Medical Virology. 75: 321-331

Immunisation at the crossroads.

McIntyre P, Kelly H, Mulholland K.
Med J Aust 2005; 182:15-16.

A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C viral load in HIV/HCV-coinfected patients.

Mijch A, Sasadeusz J, Hellard M, Dunne M, McCaw R, Bowden S, Gowans E.
Antivir Ther 2005; 10: 277-284.

Mutations affecting the replication capacity of the Hepatitis B virus.

Sheldon J, Rodés B, Zoulim F, Bartholomeusz A, Soriano V.
Journal of Viral Hepatitis 2005: in press

Selection of Hepatitis B virus polymerase mutations in human immunodeficiency virus co-infected patients treated with tenofovir.

Sheldon J, Camino N, Rodés B, Bartholomeusz A, Kuiper M, Tacke F, Núñez M, Mauss S, Lutz T, Klausen G, Locarnini S, Soriano V.
Antiviral Therapy 2005: 10(6): 727-34

Annual report of the Australian National Poliovirus Reference Laboratory, 2004.

Stambos V, Brussen KA, Thorley BR.
Commun Dis Intell. 2005;29(3):263-8.

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.

Sung J, Wong M, Bowden S, Liew C, Hui A, Wong V, Leung N, Locarnini S, Chan H.
Gastroenterology 2005;128(7):1890-1897.

Transmission of G145R mutant of HBV to an unrelated contact.

Thakur V, Kazim SN, Guptan RC, Hasnain SE, Bartholomeusz A, Malhotra V, Sarin SK.
J Med Virol 2005; 76:40-46.

Influenza surveillance in Victoria, 2004.

Turner J, Clothier H, Kaye M, Kelly H.
Commun Dis Intell 2005; 29:71-76.

A medical locum service as a sentinel site for influenza surveillance.

Turner J, Kelly H.
Eurosurveillance 2005; 10(4) available at http://www.eurosurveillance.org/em/v10n04/1004-222.asp

Failure of the Lamivudine-Resistant rtM204I Hepatitis B Virus Mutants To Efficiently Support Hepatitis Delta Virus Secretion.

Vietheer PT, Netter HJ, Sozzi T, Bartholomeusz A.
J Virol 2005; 79:6570-6573.